|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn911200717 |
003 |
OCoLC |
005 |
20231120112005.0 |
006 |
m o d |
007 |
cr cnu|||unuuu |
008 |
150619s2014 ne ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d EBLCP
|d N$T
|d IDEBK
|d OPELS
|d YDXCP
|d CDX
|d OCLCF
|d VGM
|d OCLCO
|d MERER
|d OCLCO
|d OCLCQ
|d OCLCA
|d U3W
|d OCLCO
|d D6H
|d OCLCO
|d OCLCA
|d UHL
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1105183489
|
020 |
|
|
|a 9780128039625
|q (electronic bk.)
|
020 |
|
|
|a 0128039620
|q (electronic bk.)
|
020 |
|
|
|a 9780128039618
|q (electronic bk.)
|
020 |
|
|
|a 0128039612
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)911200717
|z (OCoLC)1105183489
|
050 |
|
4 |
|a RS403
|
060 |
|
4 |
|a QV 744
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.7
|2 23
|
245 |
0 |
0 |
|a Recent advances in medicinal chemistry.
|n Volume 1 /
|c edited by Atta-ur-Rahman, Muhammad Iqbal Choudhary, George Perry.
|
264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier Ltd.,
|c [2014]
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed June 24, 2015).
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a Originally published by Bentham and now distributed by Elsevier, Recent Advances in Medicinal Chemistry, Volume 1 covers leading-edge research and recent developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies. The fourteen updated reviews include unique experimental data and references, and each article highlights an important topic in current medicinal chemistry research. Topics covered include: aureolic acid group of anti-cancer antibiotics and non-steroidal anti-inflammatory drugs; aromatase inhibitors in adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women; Rho GTPases and statins in targeting and developing therapies for tumors; and more.
|
505 |
0 |
|
|a Front Cover; Recent Advances in Medicinal Chemistry, Volume 1; Copyright; Contents ; Foreword ; Preface ; List of Contributors ; Chapter 1: New Functions of Old Drugs: Aureolic Acid Group of Anti-Cancer Antibiotics and Non-Steroidal Anti-Inflammatory Drugs ; Abstract ; 1. Introduction ; 2. Principal Functions of Nsaids and Aureolic Acid Anticancer Antibiotics and Their Mechanism of Action ; 3. Other Functions of These Drugs and Mechanism of Actions ; 4. Chemical Dissection of the Drugs to Understand Alternate Functions ; 5. Conclusion ; Acknowledgements ; Conflict of Interest ; Disclosure
|
505 |
8 |
|
|a Chapter 3: Characterization of Inorganic Nanomaterials as Therapeutic Vehicles Abstract ; Introduction ; Concluding Remarks ; Acknowledgements ; Conflict of Interest ; Disclosure ; References ; Chapter 4: Aromatase Inhibitors: A New Reality for the Adjuvant Endocrine Treatment of Early-Stage Breast Cancer in Postmenopausal Women ; Abstract ; Introduction ; Conclusions ; Acknowledgements ; Conflict of Interest ; Disclosure ; References ; Chapter 5: Bacterial FabH: Towards the Discovery of New Broad-Spectrum Antibiotics ; Abstract ; Introduction ; Bacterial Type II Fas the Biological Process
|
505 |
8 |
|
|a Three Dimensional Structure of FabH Substrate Binding and Specificity ; Catalytic Mechanism and Substrate Binding ; Molecular Modeling Studies of FabH ; Concluding Remarks ; Acknowledgements ; Conflict of Interest ; Disclosure ; References ; Chapter 6: Tannins and Their Influence on Health ; Abstract ; 1. Introduction ; 2. Classification of Tannins ; 3. Absorption and Metabolism of Tannins ; 4. Biological Activity ; 5. Human Intervention Studies ; 6. Adverse and Undesirable Effects ; 7. Conclusions ; Acknowledgements ; Conflict of Interest ; Disclosure ; Abbreviations ; References
|
505 |
8 |
|
|a Chapter 7: Rho-GTPases and Statins: A Potential Target and a Potential Therapeutic Tool Against Tumors? Abstract ; Introduction ; Role of RhoA in Normal and Tumor Cells ; Statins Inhibit RhoA Activity ; Statins and Tumor Growth/apoptosis ; Statins and Angiogenesis ; Statins and Metastasis ; Statins, Chemotherapy Efficacy and Multidrug Resistance ; Statins and Chemoprevention of Tumors ; Statins in Cancer Treatment ; Acknowledgements ; Conflict of Interest ; Disclosure ; References ; Chapter 8: Carotenoids that are Involved in Prostate Cancer Risk ; Abstract ; Introduction
|
650 |
|
0 |
|a Pharmaceutical chemistry.
|
650 |
|
2 |
|a Chemistry, Pharmaceutical
|0 (DNLM)D002626
|
650 |
|
6 |
|a Chimie pharmaceutique.
|0 (CaQQLa)201-0028674
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Pharmaceutical chemistry
|2 fast
|0 (OCoLC)fst01060115
|
700 |
1 |
|
|a Rahman, Atta-ur-,
|d 1942-
|e editor.
|
700 |
1 |
|
|a Choudhary, Muhammad Iqbal,
|e editor.
|
700 |
1 |
|
|a Perry, George,
|e editor.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128039618
|z Texto completo
|